Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 192 pages)

 

Export 2363 results:
Author Title [ Type(Desc)] Year
Journal Article
J. Watson, Jones, H. E., Banks, J., Whiting, P., Salisbury, C., and Hamilton, W., Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy, Br J Gen Pract, vol. 69, pp. e462-e469, 2019.
S. J. Roberts and Bateman, D. N., The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study, Br J Clin Pharmacol, vol. 38, pp. 489-97, 1994.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of nonsteroidal anti-inflammatory drugs and risk of fractures, Bone, vol. 27, pp. 563-8, 2000.
R. G. Schlienger, Jick, H., and Meier, C. R., Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction, Br J Clin Pharmacol, vol. 54, pp. 327-32, 2002.
J. Gorricho, Garjon, J., Alonso, A., Celaya, M. C., Saiz, L. C., Erviti, J., and Lopez, A., Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study, Br J Clin Pharmacol, vol. 83, pp. 2034-2044, 2017.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Zhang, B., and Cooper, C., Use of oral corticosteroids and risk of fractures, J Bone Miner Res, vol. 15, pp. 993-1000, 2000.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., and Cooper, C., Use of oral corticosteroids in the United Kingdom, Qjm, vol. 93, pp. 105-11, 2000.
P. C. Souverein, Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C., Leufkens, H. G., and Walker, B. R., Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, vol. 90, pp. 859-65, 2004.
A. Keyany, Nielen, J. T. H., Souverein, P. C., de Vries, F., and van den Bemt, B., Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study, Diabetes Res Clin Pract, vol. 139, pp. 100-106, 2018.
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study, Bmj, vol. 344, p. e3645, 2012.
P. Tammes, Sartini, C., Preston, I., Hay, A. D., Lasserson, D., and Morris, R. W., Use of primary care data to predict those most vulnerable to cold weather: a case-crossover analysis, Br J Gen Pract, vol. 68, pp. e146-e156, 2018.
R. L. Tannen, Weiner, M. G., and Xie, D., Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings, Bmj, vol. 338, p. b81, 2009.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, 2018.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, vol. 285, pp. 205-214, 2019.
C. Seliger, Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., and Leitzmann, M. F., Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma, PLoS One, vol. 11, p. e0149293, 2016.
C. R. Meier, Schlienger, R. G., and Jick, H., Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction, Br J Clin Pharmacol, vol. 52, pp. 179-84, 2001.
A. V. Margulis, Abou-Ali, A., Strazzeri, M. M., Ding, Y., Kuyateh, F., Frimpong, E. Y., Levenson, M. S., and Hammad, T. A., Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD, Pharmacoepidemiol Drug Saf, vol. 22, pp. 942-51, 2013.
T. P. van Staa, Wegman, S., de Vries, F., Leufkens, B., and Cooper, C., Use of statins and risk of fractures, Jama, vol. 285, pp. 1850-5, 2001.
C. Becker, Jick, S. S., and Meier, C. R., Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK, Drug Saf, vol. 31, pp. 399-407, 2008.
H. J. de Jong, Klungel, O. H., van Dijk, L., Vandebriel, R. J., Leufkens, H. G., van der Laan, J. W., Tervaert, J. W. Cohen, and Van Loveren, H., Use of statins is associated with an increased risk of rheumatoid arthritis, Ann Rheum Dis, vol. 71, pp. 648-54, 2012.
L. Huiart, Dell'Aniello, S., and Suissa, S., Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer, Br J Cancer, vol. 104, pp. 1558-63, 2011.
K. Tascilar, Azoulay, L., Dell'Aniello, S., Bartels, D. B., and Suissa, S., The Use of Telmisartan and the Incidence of Cancer, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
S. Rowlands, Devalia, H., and Lawrenson, R., Use of the combined oral contraceptive pill by under 16s, J Fam Plann Reprod Health Care, vol. 27, pp. 17-9, 2001.
A. Hansell, Hollowell, J., Nichols, T., McNiece, R., and Strachan, D., Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4), Thorax, vol. 54, pp. 413-9, 1999.
S. Donovan, The Use of the General Practice Research Database (Gprd) to Examine Potential Links between Antidepressant Medication and the Incidence of Suicide, Drug Information Journal, vol. 30, pp. 785-792, 1996.
L. A. Garcia Rodriguez and S. Gutthann, P., Use of the UK General Practice Research Database for pharmacoepidemiology, Br J Clin Pharmacol, vol. 45, pp. 419-25, 1998.
C. Meier, Kraenzlin, M. E., Bodmer, M., Jick, S. S., Jick, H., and Meier, C. R., Use of thiazolidinediones and fracture risk, Arch Intern Med, vol. 168, pp. 820-5, 2008.
J. T. Nielen, de Vries, F., Dagnelie, P. C., van den Bemt, B. J., Emans, P. J., Lalmohamed, A., de Boer, A., and Boonen, A., Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study, Br J Clin Pharmacol, vol. 81, pp. 370-8, 2016.
J. G. Kuiper, van Herk-Sukel, M. P. P., Castellsague, J., Pottegard, A., Berglind, I. A., Dedman, D., Gutierrez, L., Calingaert, B., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study, Drugs Real World Outcomes, 2018.
T. Itani, Martin, R., Rai, D., Jones, T., Taylor, G., Thomas, K., Munafo, M., Davies, N., and Taylor, A., Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records, BMJ Open, vol. 9, p. e027569, 2019.
C. Martinez, Assimes, T. L., Mines, D., Dell'Aniello, S., and Suissa, S., Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study, Bmj, vol. 340, p. c249, 2010.
M. Ozawa, Brennan, P. M., Zienius, K., Kurian, K. M., Hollingworth, W., Weller, D., Grant, R., Hamilton, W., and Ben-Shlomo, Y., The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014), BMJ Open, vol. 9, p. e029686, 2019.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., Users of oral steroids are at a reduced risk of developing irritable bowel syndrome, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
M. Asaria, Walker, S., Palmer, S., Gale, C. P., Shah, A. D., Abrams, K. R., Crowther, M., Manca, A., Timmis, A., Hemingway, H., and Sculpher, M., Using electronic health records to predict costs and outcomes in stable coronary artery disease, Heart, vol. 102, pp. 755-62, 2016.
S. S. Zghebi, Rutter, M. K., Ashcroft, D. M., Salisbury, C., Mallen, C., Chew-Graham, C. A., Reeves, D., van Marwijk, H., Qureshi, N., Weng, S., Peek, N., Planner, C., Nowakowska, M., Mamas, M., and Kontopantelis, E., Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design, BMJ Open, vol. 8, p. e020926, 2018.
S. E. Bromley, de Vries, C. S., and Farmer, R. D., Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database, Bjog, vol. 111, pp. 369-76, 2004.
A. Dregan, Toschke, M. A., Wolfe, C. D., Rudd, A., Ashworth, M., and Gulliford, M. C., Utility of electronic patient records in primary care for stroke secondary prevention trials, BMC Public Health, vol. 11, p. 86, 2011.
S. L. Stevens, McManus, R. J., and Stevens, R. J., The utility of long-term blood pressure variability for cardiovascular risk prediction in primary care, J Hypertens, 2018.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Utility of medical and drug history in fracture risk prediction among men and women, Bone, vol. 31, pp. 508-14, 2002.
P. J. Helms, S. Daukes, E., Taylor, M. W., Simpson, C. R., and McLay, J. S., Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology, Br J Clin Pharmacol, vol. 59, pp. 684-90, 2005.
K. E. Wurst, Ephross, S. A., Loehr, J., Clark, D. W., and Guess, H. A., The utility of the general practice research database to examine selected congenital heart defects: a validation study, Pharmacoepidemiol Drug Saf, vol. 16, pp. 867-77, 2007.
A. M. Gallagher, Leighton-Scott, J., and van Staa, T. P., Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study, Clin Ther, vol. 31, pp. 1707-15, 2009.
T. A. Durham, K. Lich, H., Viera, A. J., Fine, J. P., Mukherjee, J., Weinberger, M., and Dusetzina, S. B., Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation, Am J Cardiol, vol. 120, pp. 1820-1829, 2017.
T. Burkard, Moser, M., Rauch, M., Jick, S. S., and Meier, C. R., Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study, Menopause, 2019.
T. M. McKeever, Lewis, S. A., Smith, C., and Hubbard, R., Vaccination and allergic disease: a birth cohort study, Am J Public Health, vol. 94, pp. 985-9, 2004.
S. A. Bremner, Carey, I. M., DeWilde, S., Richards, N., Maier, W. C., Hilton, S. R., Strachan, D. P., and Cook, D. G., Vaccinations, infections and antibacterials in the first grass pollen season of life and risk of later hayfever, Clin Exp Allergy, vol. 37, pp. 512-7, 2007.
J. E. Amegadzie, Badejo, O., Gamble, J. M., Wright, M., Farrell, J., Jackson, B., Sultana, K., Hashmi, M., and Gao, Z., Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol, BMJ Open, vol. 9, p. e024306, 2019.
R. P. Cornish, Henderson, J., Boyd, A. W., Granell, R., Van Staa, T., and Macleod, J., Validating childhood asthma in an epidemiological study using linked electronic patient records, BMJ Open, vol. 4, p. e005345, 2014.
J. A. Delaney, Moodie, E. E., and Suissa, S., Validating the effects of drug treatment on blood pressure in the General Practice Research Database, Pharmacoepidemiol Drug Saf, vol. 17, pp. 535-45, 2008.
E. Herrett, Thomas, S. L., Schoonen, W. M., Smeeth, L., and Hall, A. J., Validation and validity of diagnoses in the General Practice Research Database: a systematic review, Br J Clin Pharmacol, vol. 69, pp. 4-14, 2010.
[Page last reviewed 4 November 2019]